AstraZeneca PLC
AZNCF
$147.50
$0.110.08%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 6.40% | -8.75% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.40% | -8.75% | |||
| Cost of Revenue | 14.24% | -20.56% | |||
| Gross Profit | 4.85% | -6.00% | |||
| SG&A Expenses | 8.96% | -11.32% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 36.84% | -185.00% | |||
| Total Operating Expenses | 12.03% | -14.91% | |||
| Operating Income | -8.14% | 12.21% | |||
| Income Before Tax | -8.08% | 104.20% | |||
| Income Tax Expenses | 41.16% | 189.76% | |||
| Earnings from Continuing Operations | -16.19% | 94.73% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 140.00% | -- | |||
| Net Income | -15.98% | 94.40% | |||
| EBIT | -8.14% | 12.21% | |||
| EBITDA | -4.02% | 21.10% | |||
| EPS Basic | -15.98% | 94.41% | |||
| Normalized Basic EPS | -11.57% | 14.78% | |||
| EPS Diluted | -16.05% | 94.21% | |||
| Normalized Diluted EPS | -11.46% | 14.87% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | -0.13% | -0.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -1.00% | 572.90% | |||